New Zealand markets closed

ChenGuang Biotech Group Co., Ltd. (300138.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
8.96-0.35 (-3.76%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.77B
Enterprise value 7.41B
Trailing P/E 12.43
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.70
Price/book (mrq)1.42
Enterprise value/revenue 1.09
Enterprise value/EBITDA 13.84

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3-48.68%
S&P500 52-week change 323.49%
52-week high 318.28
52-week low 38.90
50-day moving average 310.28
200-day moving average 312.65

Share statistics

Avg vol (3-month) 38.18M
Avg vol (10-day) 34.41M
Shares outstanding 5532.77M
Implied shares outstanding 6532.77M
Float 8367.57M
% held by insiders 132.48%
% held by institutions 111.84%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.16
Forward annual dividend yield 41.62%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.60
Payout ratio 422.20%
Dividend date 3N/A
Ex-dividend date 417 May 2023
Last split factor 21.4:1
Last split date 327 Jun 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.74%
Operating margin (ttm)4.30%

Management effectiveness

Return on assets (ttm)3.45%
Return on equity (ttm)11.17%

Income statement

Revenue (ttm)6.79B
Revenue per share (ttm)12.76
Quarterly revenue growth (yoy)-4.70%
Gross profit (ttm)N/A
EBITDA 583.43M
Net income avi to common (ttm)389.17M
Diluted EPS (ttm)0.72
Quarterly earnings growth (yoy)-71.40%

Balance sheet

Total cash (mrq)2.24B
Total cash per share (mrq)4.36
Total debt (mrq)4.88B
Total debt/equity (mrq)142.66%
Current ratio (mrq)1.61
Book value per share (mrq)6.56

Cash flow statement

Operating cash flow (ttm)-255.19M
Levered free cash flow (ttm)-474.81M